Literature DB >> 27062876

Adaptability and potential for treatment of placental functions to improve embryonic development and postnatal health.

James C Cross1.   

Abstract

For an organ that is so critical for life in eutherian mammals, the placenta hardly gets the attention that it deserves. The placenta does a series of remarkable things, including implanting the embryo in the uterus, negotiating with the mother for nutrients but also protecting her health during pregnancy, helping establish normal metabolic and cardiovascular function for life postnatally (developmental programming) and initiating changes that prepare the mother to care for and suckle her young after birth. Different lines of evidence in experimental animals suggest that the development and function of the placenta are adaptable. This means that some of the changes observed in pathological pregnancies may represent attempts to mitigate the impact of fetal growth and development. Key and emerging concepts are reviewed here concerning how we may view the placenta diagnostically and therapeutically in pregnancy complications, focusing on information from experimental studies in mice, sheep and cattle, as well as association studies from humans. Hundreds of different genes have been shown to underlie normal placental development and function, some of which have promise as tractable targets for intervention in pregnancies at risk for poor fetal growth.

Entities:  

Mesh:

Year:  2016        PMID: 27062876     DOI: 10.1071/RD15342

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  4 in total

1.  The Placental Atlas Tool (PAT): A collaborative research and discovery platform for the placental research community.

Authors:  John V Ilekis; Michael Keller; Alexandra Shlionskaya; Christopher H Ferguson; Bianca Patel; Alexander Lobkovsky Meitiv; Bryan Gorman; Archana Mohale
Journal:  Placenta       Date:  2019-04-01       Impact factor: 3.481

Review 2.  Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders.

Authors:  Louise Fliedel; Khair Alhareth; Nathalie Mignet; Thierry Fournier; Karine Andrieux
Journal:  Biomedicines       Date:  2022-04-19

3.  The platelet-derived growth factor receptor alpha promoter-directed expression of cre recombinase in mouse placenta.

Authors:  Jean-Sebastien Wattez; Liping Qiao; Samuel Lee; David Renato Christopher Natale; Jianhua Shao
Journal:  Dev Dyn       Date:  2019-03-27       Impact factor: 3.780

4.  Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction.

Authors:  Malcolm Eaton; Alastair H Davies; Jay Devine; Xiang Zhao; David G Simmons; Elín Maríusdóttir; David R C Natale; John R Matyas; Elizabeth A Bering; Matthew L Workentine; Benedikt Hallgrimsson; James C Cross
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.